BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 23426790)

  • 1. Anti-inflammatory effects of total alkaloids from Rubus alceifolius Poir [corrected]. on non-alcoholic fatty liver disease through regulation of the NF-κB pathway.
    Zhao J; Zheng H; Liu Y; Lin J; Zhong X; Xu W; Hong Z; Peng J
    Int J Mol Med; 2013 Apr; 31(4):931-7. PubMed ID: 23426790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effects and mechanisms of total alkaloids of Rubus alceaefolius Poir on non‑alcoholic fatty liver disease in rats.
    Zheng H; Zhao J; Zheng Y; Wu J; Liu Y; Peng J; Hong Z
    Mol Med Rep; 2014 Oct; 10(4):1758-64. PubMed ID: 25051256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of total alkaloids of Rubus alceaefolius on oxidative stress in rats with non-alcoholic fatty liver disease].
    Zheng H; Zhao J; Liu Y; Zheng Y; Wu J; Hong Z
    Zhongguo Zhong Yao Za Zhi; 2011 Sep; 36(17):2383-7. PubMed ID: 22121808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total alkaloids of Rubus aleaefolius Poir inhibit hepatocellular carcinoma growth in vivo and in vitro via activation of mitochondrial-dependent apoptosis.
    Zhao J; Chen X; Lin W; Wu G; Zhuang Q; Zhong X; Hong Z; Peng J
    Int J Oncol; 2013 Mar; 42(3):971-8. PubMed ID: 23338043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Hepatocellular Carcinoma by Total Alkaloids of Rubus alceifolius Poir Involves Suppression of Hedgehog Signaling.
    Zhao J; Liu L; Wan Y; Zhang Y; Zhuang Q; Zhong X; Hong Z; Peng J
    Integr Cancer Ther; 2015 Jul; 14(4):394-401. PubMed ID: 25917815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pioglitazone ameliorates nonalcoholic steatohepatitis by down-regulating hepatic nuclear factor-kappa B and cyclooxygenases-2 expression in rats.
    Zhao JS; Zhu FS; Liu S; Yang CQ; Chen XM
    Chin Med J (Engl); 2012 Jul; 125(13):2316-21. PubMed ID: 22882855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Purple sweet potato anthocyanins attenuates steatohepatitis induced by high fat diet combined with carbon tetrachloride in rats].
    Mi W; Han F; Liang J; Liang Y; Guan B; Xu H
    Wei Sheng Yan Jiu; 2018 Jul; 47(4):517-524. PubMed ID: 30081974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ANTI-INFLAMMATORY ACTIVITY OF PLATYCODIN D ON ALCOHOL-INDUCED FATTY LIVER RATS VIA TLR4-MYD88-NF-κB SIGNAL PATH.
    Wu JT; Yang GW; Qi CH; Zhou L; Hu JG; Wang MS
    Afr J Tradit Complement Altern Med; 2016; 13(4):176-183. PubMed ID: 28852734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of nuclear factor-κB and angiotensin II receptor type 1 on the pathogenesis of rat non-alcoholic fatty liver disease.
    Tan DY; Shi HY; Li CP; Zhong XL; Kang M
    World J Gastroenterol; 2015 May; 21(19):5877-83. PubMed ID: 26019451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-inflammatory effect of genistein on non-alcoholic steatohepatitis rats induced by high fat diet and its potential mechanisms.
    Ji G; Yang Q; Hao J; Guo L; Chen X; Hu J; Leng L; Jiang Z
    Int Immunopharmacol; 2011 Jun; 11(6):762-8. PubMed ID: 21320636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total alkaloids of Rubus alceifolius Poir shows anti-angiogenic activity in vivo and in vitro.
    Zhao J; Lin W; Zhuang Q; Zhong X; Cao Z; Hong Z; Peng J
    Integr Cancer Ther; 2014 Nov; 13(6):520-8. PubMed ID: 25148840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artemisia capillaris formula inhibits hepatic steatosis via an miR‑122‑induced decrease in fatty acid synthase expression in vivo and in vitro.
    Liu L; Zhao J; Li Y; Wan Y; Lin J; Shen A; Xu W; Li H; Zhang Y; Xu J; Peng J; Hong Z
    Mol Med Rep; 2016 Jun; 13(6):4751-8. PubMed ID: 27081834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Celecoxib attenuates liver steatosis and inflammation in non-alcoholic steatohepatitis induced by high-fat diet in rats.
    Chen J; Liu D; Bai Q; Song J; Guan J; Gao J; Liu B; Ma X; Du Y
    Mol Med Rep; 2011; 4(5):811-6. PubMed ID: 21643627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polydatin alleviates non-alcoholic fatty liver disease in rats by inhibiting the expression of TNF-α and SREBP-1c.
    Zhang J; Tan Y; Yao F; Zhang Q
    Mol Med Rep; 2012 Oct; 6(4):815-20. PubMed ID: 22858825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory effect of a Chinese herbal medicine formula on non-alcoholic fatty liver disease.
    Yang JM; Sun Y; Wang M; Zhang XL; Zhang SJ; Gao YS; Chen L; Wu MY; Zhou L; Zhou YM; Wang Y; Zheng FJ; Li YH
    World J Gastroenterol; 2019 Sep; 25(34):5105-5119. PubMed ID: 31558860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total alkaloids of Rubus aleaefolius Poir. inhibit the STAT3 signaling pathway leading to suppression of proliferation and cell cycle arrest in a mouse model of hepatocellular carcinoma.
    Zhao J; Lin W; Cao Z; Liu L; Zhuang Q; Zhong X; Hong Z; Peng J
    Oncol Rep; 2013 Sep; 30(3):1309-14. PubMed ID: 23828071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Voluntary oral feeding of rats not requiring a very high fat diet is a clinically relevant animal model of non-alcoholic fatty liver disease (NAFLD).
    Tipoe GL; Ho CT; Liong EC; Leung TM; Lau TY; Fung ML; Nanji AA
    Histol Histopathol; 2009 Sep; 24(9):1161-9. PubMed ID: 19609863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mechanism of catgut embedding at back-
    Zhou XL; Tang N; Wu T; Zhang Y; Chen Q; Wei WH; Zhou YN; Zhang DX; Qin FC; Yang W
    Zhongguo Zhen Jiu; 2020 Jan; 40(1):59-66. PubMed ID: 31930901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Berberine inhibits liver damage in rats with non-alcoholic fatty liver disease by regulating TLR4/MyD88/NF-κB pathway.
    Wang L; Jia Z; Wang B; Zhang B
    Turk J Gastroenterol; 2020 Dec; 31(12):902-909. PubMed ID: 33626003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Nonalcoholic Fatty Liver Disease with Total Alkaloids in Rubus aleaefolius Poir through Regulation of Fat Metabolism.
    Li Y; Zhao J; Zheng H; Zhong X; Zhou J; Hong Z
    Evid Based Complement Alternat Med; 2014; 2014():768540. PubMed ID: 25404949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.